| Application no. and date | 20780467.5 (espacenet) (Federated) (European Patent Register), 20200910 | | Patent/reg. no. and date | DK/EP 4027983, 20251119 | | Publication date | 20220720 | | Priority no. and date | US 201962899070 P, 20190911, US 201962913648 P, 20191010, WO PCT/US2019/062066, 20191118, US 202062959784 P, 20200110, US 202062971835 P, 20200207, US 202063019190 P, 20200501, US 202063030819 P, 20200527, US 202063063203 P, 20200807 | | EP pub. no. and date |
EP 4027983 20220720 | | Effective date | | | Applicant/owner | Adverum Biotechnologies, Inc., 100 Cardinal Way
Redwood City, CA 94063, US | | Applicant ref. no. | BB391804EPDK | | Inventor | GASMI, Mehdi,
Redwood City, California 94063, US,
TURPCU, Adam,
Redwood City, California 94063, US,
KISS, Szilard,
Redwood City, California 94063, US,
OSBORNE, Aaron,
Redwood City, California 94063, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 35/761 (2015.01) , A61K 38/17 (2006.01) , A61P 27/02 (2006.01) , C12N 15/86 (2006.01) , C12N 7/00 (2006.01) | | Title | BEHANDLING AF NEOVASKULÆRE ØJENSYGDOMME MED AAV2-VARIANTER, DER KODER FOR AFLIBERCEPT | | Int. application no. | US2020050079 | | Int. publication no. | WO2021050649 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
